Meditrade Medical Trading GMBH

Meditrade Medical Trading GMBH, doing business as Meditrade GMBH, supplies diagnostic test kits, laboratory reagents, specialized medical cartridges, and medical equipment maintenance services to U.S. defense healthcare operations as a prime contractor, competing without set-aside protections in the open federal marketplace. The for-profit limited liability company, headquartered in Oyten, Germany, has held active federal contractor status since September 2004 and operates across NAICS 339113 (Surgical Appliance and Supplies Manufacturing) and PSC 6515 (Medical and Surgical Instruments, Equipment, and Supplies), with work performed in Germany supporting military personnel stationed overseas.

Meditrade's customer concentration is extreme and singular. The Army Medical Command accounts for 307 awards carrying $46.2 million in combined potential value—75% of the vendor's entire active federal footprint. The Defense Health Agency represents 35 awards worth $8.9 million, and the Defense Logistics Agency Troop Support Medical carries 761 awards totaling $5.4 million, but the potential-value rankings reveal the reality: Army Medical Command dominates. That concentration reflects two single-award Blanket Purchase Agreements, each valued at $2 million through June 29, 2026, that anchor the bulk of Meditrade's recurring delivery-order activity. A newer Defense Health Agency indefinite-delivery contract awarded December 1, 2025, carries a $3.64 million ceiling through September 30, 2030, for laboratory testing supplies for Hologic analyzers at Landstuhl Regional Medical Center, and a June 30, 2026 Army Medical Command BPA established a $950 thousand vehicle through June 29, 2028.

Recent capability work centers on rapid fulfillment of high-volume, low-value delivery orders. Representative awards include a $263.9 thousand Defense Health Agency delivery order (December 2025) for laboratory testing supplies supporting Landstuhl Regional Medical Center; a $300.8 thousand Defense Health Agency purchase order (February 2026) for sterilizer and washer maintenance services at Landstuhl; a $115.3 thousand Defense Health Agency purchase order (January 2026) for Life Tech incubator equipment repairs; a $76.8 thousand Defense Health Agency purchase order (July 2026) for an argon enhanced coagulation gas delivery unit supporting Landstuhl gastroenterology; and a $16.5 thousand Army Medical Command annual maintenance order (August 2026) for a Thermo Fisher Scientific Applied Biosystems 7500 Fast DX real-time PCR instrument. The bulk of the portfolio—760 delivery orders under a Defense Logistics Agency IDC (SPE2DS23D0001) and 29 task orders under an Army Medical Command BPA—consists of cartridge chemistry tests (CG8, CHEM 8+), SARS-CoV-2/flu/RSV diagnostic test kits, hepatitis B surface antigen test determinant kits, D-dimer triage tests, basic and cardiac metabolic panels, blood control sets, and specialized medical cartridges, with individual orders ranging from under one hundred dollars to $28.7 thousand.

Activity trajectory shows mature, volume-heavy performance: twelve awards in 2022, two hundred in 2023, two hundred forty-one in 2024, two hundred thirty-six in 2025, and one hundred thirty through August 2026. Combined potential value across all one thousand one hundred ninety-six awards stands at $61.5 million, with $25.1 million obligated (41%). Six awards face ultimate completion inside the next twenty-four months, totaling $1.1 million in potential value, representing moderate recompete exposure. Meditrade does not hold a position as a subcontractor on other federal primes; all awards are prime contractor roles with no sub-award footprint recorded.